Related Experiment Video
Updated: Nov 2, 2025
07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.1K
Scaling technician product verification: Contextual analysis for developing an implementation strategy for a large
Summary
Implementing technician product verification (TPV) in community pharmacies is complex. Success hinges on adaptability, organizational climate, and evolving staff beliefs, requiring TPV to be a primary workflow, not optional.
Area of Science:
- Pharmacy Practice
- Implementation Science
- Healthcare Management
Background:
- Community pharmacies face evolving roles and workflow demands.
- Delegation of tasks, such as product verification, to pharmacy technicians is a key strategy.
- Technician Product Verification (TPV) represents an expansion of the technician role.
Purpose of the Study:
- To identify facilitators and barriers to the early implementation of a TPV program.
- To develop a scalable strategy for accelerating TPV adoption in community pharmacy chains.
- To understand the factors influencing the successful integration of TPV into existing workflows.
Main Methods:
- A mixed-methods approach combining surveys, semistructured interviews, and direct observation.
- Qualitative data collection through one-on-one staff interviews and observations.
- Quantitative data collection via a Web-based survey to assess perceptions of implementation strategies.
Main Results:
- TPV implementation is complex, influenced by adaptability, trialability, and state regulations.
- The pharmacy organization's implementation climate significantly facilitates TPV adoption.
- Individual beliefs and perceptions regarding TPV evolve with implementation experience.
Conclusions:
- TPV facilitates pharmacy's capacity for clinical activities by delegating non-clinical tasks.
- Successful TPV requires viewing it as a primary workflow, not an optional task.
- Sustained TPV success depends on staff buy-in, patience, and dedicated championship.
More Related Videos
Related Concept Videos
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
55
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
55
01:26Drug Administration and Therapy Phases: Overview
929
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
929
01:12Analysis of Population Pharmacokinetic Data
503
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
503
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.9K
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
42
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
42
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
60
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
60